TradingMarkets’ 6 Stocks You Need To Know About Today
Genentech
(
DNA |
Quote |
Chart |
News |
PowerRating) and OSI Pharmaceuticals
(
OSIP |
Quote |
Chart |
News |
PowerRating) said
that Phase III trials of Avastin showed a 30% improvement in survival rates in
cancer patients.
Celgene
(
CELG |
Quote |
Chart |
News |
PowerRating) reported good results on its Revlimid.
Limited Brands
(
LTD |
Quote |
Chart |
News |
PowerRating) missed by 0.02 and warned for Q2.
Lowes
(
LOW |
Quote |
Chart |
News |
PowerRating) missed but profits and revenues rose.
Advanced Micro Devices
(
AMD |
Quote |
Chart |
News |
PowerRating) was raised to a buy at Legg Mason.